Connect with us

Coronavirus Vaccine

India’s Serum Institute Says Made 40 Million Doses Of AstraZeneca’s COVID Vaccine, To Make Novavax Shot Soon

Serum Institute of India said that it had enrolled 1,600 participants in India for the late-stage trials of AstraZeneca’s candidate, and also plans to seek regulatory approval to run late-stage trials for the Novavax vaccine

India's Serum Institute Says Made 40 Million Doses Of AstraZeneca's COVID Vaccine, To Make Novavax Shot Soon
Highlights
  • While there are no COVID-19 vaccines approved yet, trials are underway
  • Novavax is testing its vaccine in a late stage study in the United Kingdom
  • The AstraZeneca-Oxford vaccine is the most advanced one in the country

Bengaluru: Serum Institute of India, the world’s largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca’s potential COVID-19 vaccine, and would soon begin making Novavax’s rival shot, as they both seek regulatory approval. While there are no COVID-19 vaccines approved yet and trials are still underway to prove they are safe and effective, leading drugmakers have been funded to begin production early to expedite deliveries, as the pandemic has killed more than 1.2 million people worldwide.

Also Read: COVID-19 Vaccine In India: ICMR, Serum Institute Of India Complete Enrolment Of Phase 3 Clinical Trials For Covishield

AstraZeneca said last week that it was holding back deliveries of its COVID-19 vaccine candidate while it awaits the data from late-stage clinical trials, which got delayed due to a summer dip in UK coronavirus infections. Serum declined to comment on whether the 40 million doses of the AstraZeneca vaccine were meant for global supply or only for India.

For the production of the Novavax vaccine, Serum said it has received the bulk of the vaccine from the U.S. company and will soon fill and finish them in vials.

Novavax, which is testing its vaccine in a late-stage study in the UK, last month postponed the start of its U.S. trial by roughly a month due to delays in scaling up the manufacturing process.

Serum said it had enrolled 1,600 participants in India for the late-stage trials of AstraZeneca’s candidate, and also plans to seek regulatory approval to run late-stage trials for the Novavax vaccine.

Also Read: Fight Against COVID-19: With 90% Effective Vaccine, Pfizer Keen On Marketing In India But Cold Chain A Challenge

The AstraZeneca vaccine, co-developed by Oxford University, is the most advanced in human testing in India, Serum said, adding that the company and the Indian Council of Medical Research (ICMR) will pursue “early availability” of the shot in India. The ICMR, a federal government body, had funded the clinical trial site fees for the AstraZeneca vaccine, Serum said. The company and the ICMR are currently conducting Phase 2/3 clinical trials of the shot at 15 centres across India.

The news came as coronavirus infections in India, the world’s second-worst hit country, reached 8.68 million on Thursday and the death toll increased to more than 128,000.

India also has at least two home-grown COVID-19 vaccine candidates in development, while local drugmaker Dr Reddy’s Labs is carrying out a trial in the country for Russia’s vaccine candidate.

Earlier this week, Pfizer and its partner BioNTech said their vaccine candidate had proven more than 90% effective based on initial trial results. Pfizer said it was committed to advancing its engagement with India’s government to supply its potential vaccine in the country.

Also Read: Sputnik V COVID-19 Vaccine Is 92 Per Cent Effective: Russia

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)

NDTV – Dettol Banega Swasth India campaign is an extension of the five-year-old Banega Swachh India initiative helmed by Campaign Ambassador Amitabh Bachchan. It aims to spread awareness about critical health issues facing the country. In wake of the current COVID-19 pandemic, the need for WASH (WaterSanitation and Hygiene) is reaffirmed as handwashing is one of the ways to prevent Coronavirus infection and other diseases. The campaign highlights the importance of nutrition and healthcare for women and children to prevent maternal and child mortality, fight malnutrition, stunting, wasting, anaemia and disease prevention through vaccines. Importance of programmes like Public Distribution System (PDS), Mid-day Meal Scheme, POSHAN Abhiyan and the role of Aganwadis and ASHA workers are also covered. Only a Swachh or clean India where toilets are used and open defecation free (ODF) status achieved as part of the Swachh Bharat Abhiyan launched by Prime Minister Narendra Modi in 2014, can eradicate diseases like diahorrea and become a Swasth or healthy India. The campaign will continue to cover issues like air pollutionwaste managementplastic banmanual scavenging and sanitation workers and menstrual hygiene

World

24,50,12,529Cases
20,64,25,824Active
3,36,14,434Recovered
49,72,271Deaths
Coronavirus has spread to 195 countries. The total confirmed cases worldwide are 24,50,12,529 and 49,72,271 have died; 20,64,25,824 are active cases and 3,36,14,434 have recovered as on October 28, 2021 at 4:00 am.

India

3,42,31,809 16,156Cases
1,60,9891,672Active
3,36,14,434 17,095Recovered
4,56,386 733Deaths
In India, there are 3,42,31,809 confirmed cases including 4,56,386 deaths. The number of active cases is 1,60,989 and 3,36,14,434 have recovered as on October 28, 2021 at 2:30 am.

State Details

State Cases Active Recovered Deaths
Maharashtra

66,06,536 1,485

23,096 3,500

64,43,342 4,947

1,40,098 38

Kerala

49,38,603 9,445

77,158 2,100

48,31,468 6,723

29,977 622

Karnataka

29,86,835 282

8,459 80

29,40,339 349

38,037 13

Tamil Nadu

26,98,493 1,075

12,288 252

26,50,145 1,315

36,060 12

Andhra Pradesh

20,64,854 567

4,777 122

20,45,713 437

14,364 8

Uttar Pradesh

17,10,114 13

100 6

16,87,115 7

22,899

West Bengal

15,89,042 976

7,973 124

15,61,973 837

19,096 15

Delhi

14,39,709 38

348 25

14,14,270 13

25,091

Odisha

10,39,818 549

4,392 213

10,27,108 334

8,318 2

Chhattisgarh

10,05,926 28

263 14

9,92,088 12

13,575 2

Rajasthan

9,54,411 4

20 0

9,45,437 4

8,954

Gujarat

8,26,481 17

173 2

8,16,220 15

10,088

Madhya Pradesh

7,92,804 20

108 9

7,82,172 10

10,524 1

Haryana

7,71,204 15

133 5

7,61,022 10

10,049

Bihar

7,26,073 5

41 1

7,16,371 4

9,661

Telangana

6,70,829 186

4,164 63

6,62,714 122

3,951 1

Assam

6,09,506 244

3,838 153

5,99,681 391

5,987 6

Punjab

6,02,289 38

246 20

5,85,487 16

16,556 2

Jharkhand

3,48,705 28

160 30

3,43,408 56

5,137 2

Uttarakhand

3,43,861 17

150 6

3,36,312 23

7,399

Jammu And Kashmir

3,31,865 70

838 16

3,26,596 86

4,431

Himachal Pradesh

2,23,406 261

1,972 211

2,17,693 48

3,741 2

Goa

1,77,969 23

454 29

1,74,152 51

3,363 1

Puducherry

1,27,846 40

443 10

1,25,546 50

1,857

Manipur

1,23,473 70

844 29

1,20,712 97

1,917 2

Mizoram

1,19,496 547

7,320 446

1,11,752 991

424 2

Tripura

84,438 15

123 1

83,499 14

816

Meghalaya

83,466 51

507 22

81,511 71

1,448 2

Chandigarh

65,331 5

29 2

64,482 3

820

Arunachal Pradesh

55,120 6

115 22

54,725 28

280

Sikkim

31,925 13

177 1

31,353 12

395

Nagaland

31,759 12

222 3

30,856 15

681

Ladakh

20,925 8

47 6

20,670 2

208

Dadra And Nagar Haveli

10,682 1

6 0

10,672 1

4

Lakshadweep

10,365

0 0

10,314

51

Andaman And Nicobar Islands

7,650 2

5 1

7,516 1

129

Coronavirus Outbreak: Full CoverageTesting CentresFAQs

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Highlights From The 12-Hour Telethon

Leaving No One Behind

Mental Health

Environment

Join Us